DK1311679T3 - Method of Inhibiting IL-22-Induced PAP1 - Google Patents

Method of Inhibiting IL-22-Induced PAP1

Info

Publication number
DK1311679T3
DK1311679T3 DK01946010T DK01946010T DK1311679T3 DK 1311679 T3 DK1311679 T3 DK 1311679T3 DK 01946010 T DK01946010 T DK 01946010T DK 01946010 T DK01946010 T DK 01946010T DK 1311679 T3 DK1311679 T3 DK 1311679T3
Authority
DK
Denmark
Prior art keywords
pap1
inhibiting
induced
induced pap1
Prior art date
Application number
DK01946010T
Other languages
Danish (da)
Inventor
Audrey Goddard
Austin L Gurney
William I Wood
Sudeepta Aggarwal
Jessica S Foster
Ellen M Maruoka
Ming-Hong Xie
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56290147&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1311679(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US2001/017443 external-priority patent/WO2002016611A2/en
Application granted granted Critical
Publication of DK1311679T3 publication Critical patent/DK1311679T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK01946010T 2000-08-24 2001-05-30 Method of Inhibiting IL-22-Induced PAP1 DK1311679T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2000/023328 WO2001016318A2 (en) 1999-09-01 2000-08-24 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/017443 WO2002016611A2 (en) 2000-08-24 2001-05-30 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders

Publications (1)

Publication Number Publication Date
DK1311679T3 true DK1311679T3 (en) 2009-02-23

Family

ID=56290147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01946010T DK1311679T3 (en) 2000-08-24 2001-05-30 Method of Inhibiting IL-22-Induced PAP1

Country Status (6)

Country Link
EP (1) EP1311679B1 (en)
JP (1) JP3886899B2 (en)
AU (1) AU2001268108A1 (en)
CA (1) CA2419541C (en)
DK (1) DK1311679T3 (en)
ES (1) ES2316454T3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006082851A1 (en) * 2005-02-02 2008-06-26 国立大学法人 東京大学 Epiglycanin related mucin
CN108290058B (en) 2015-09-17 2023-05-16 美国安进公司 Predicting clinical response of IL23 antagonists using IL23 pathway biomarkers
WO2018097646A1 (en) * 2016-11-24 2018-05-31 이형근 Composition for diagnosis of diseases
KR102536314B1 (en) * 2018-05-23 2023-05-25 주식회사 휴벳바이오 Composition for diagnosing disease

Also Published As

Publication number Publication date
CA2419541C (en) 2012-01-10
JP3886899B2 (en) 2007-02-28
CA2419541A1 (en) 2002-02-28
ES2316454T3 (en) 2009-04-16
JP2004520811A (en) 2004-07-15
EP1311679A2 (en) 2003-05-21
AU2001268108A1 (en) 2002-03-04
EP1311679B1 (en) 2008-10-22

Similar Documents

Publication Publication Date Title
DK1132569T3 (en) Method of treating an underground formation
DK1257954T3 (en) Method of distributing shipments
DK1312239T3 (en) Techniques for suppressing interference
DK1249151T3 (en) Method of Cell Selection Signaling
DK1071745T3 (en) Method for synthesizing COX-2 inhibitors
DK2258688T3 (en) Pyridinone derivatives for the treatment of atherosclerosis
DK1296935T3 (en) Process for the preparation of substituted octanoylamides
DE60211317D1 (en) RHO-KINASE INHIBITORS
DE60218138D1 (en) RHO-KINASE INHIBITORS
DK1132570T3 (en) Compositions for acid treatment of wells
DK1350765T3 (en) Method of Preparation of Iron Oxides
DK1458447T3 (en) Combination of cytochrome-p450-dependent protease inhibitors
DK1272488T3 (en) Tri-aryl-substituted ethane-PDE4 inhibitors
DK1414492T3 (en) Method of treating multiple myeloma
DK1353923T3 (en) Improved method of synthesis of carbapenem
IS6012A (en) Method of extracting metal
DK1337547T3 (en) NUCLEASE-BASED PROCEDURE FOR THE DETECTION AND QUANTIFICATION OF OIGONUCLEOTIDES
DK1314824T3 (en) Method of consolidating land
DK1345944T3 (en) Method for isolating and purifying epothilones
DK1326836T3 (en) Process for Preparation of 3-Amino-2-chloro-4-methylpyridine
DK1294659T3 (en) Method of isolating catamine
DK1309323T3 (en) Method of treating angiogenesis-related disorders
DK1169271T3 (en) Method for remediation of water-carrying layers
DK1066276T3 (en) Method of synthesis of HIV protease inhibitor
DK1311679T3 (en) Method of Inhibiting IL-22-Induced PAP1